CGHJC - GALLIUM CITRATE GA 67 INJECTION

  • MSDS: CGHJC
  • Manufacturer: MALLINCKRODT MEDICAL INC
  • Product Name: GALLIUM CITRATE GA 67 INJECTION
  • National Stock Number: 6505-00F030804
Product Identification

Product ID:GALLIUM CITRATE GA 67 INJECTION
MSDS Date:01/01/1997
FSC:6505
NIIN:00F030804
MSDS Number: CGHJC

Responsible Party
MALLINCKRODT MEDICAL INC
2703 WAGNER PLACE
MARYLAND HEIGHTS, MO 63043-3421
US

Emergency Phone: 314-770-7800

Info Phone: 314-770-7800/314-895-2000

Cage: FO650

Contractor
MALLINCKRODT MEDICAL INC
MARYLAND HEIGHTS, MO 63043-3421 US

Telephone: 314-770-7800/314-895-2000

Cage: FO650

Ingredients

GALLIUM CITRATE *97-4*

CAS: 41183-64-6

Fraction By Weight: <0.001%


SODIUM CHLORIDE *97-4*

CAS: 7647-14-5

RTECS: VZ4725000

Fraction By Weight: <1%


BENZYL ALCOHOL

CAS: 100-51-6

RTECS: DN3150000

Fraction By Weight: <1%


SODIUM CITRATE

CAS: 6132-04-3

Fraction By Weight: <1%


WATER

CAS: 7732-18-5

RTECS: ZC0110000

Fraction By Weight: >99%

Hazards

Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INGESTION: MAY CAUSE A SYMPTOMATIC
PHYSIOLOGICAL UPTAKE BY THYROID GLAND/OTHER TISSUES. EYES:
MECHANICAL IRRITATION.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRRITATION.

First Aid

First Aid:SKIN: WASH AREA THOROUGHLY W/SOAP & WATER. ALWAYS BLOT DRY.
DON'T ABRADE. EYES: WASH W/WATER FOR 15 MINS. OBTAIN MEDICAL
ATTENTION IN ALL CASES.

Fire Fighting

Extinguishing Media:USE ANY MEANS SUITABLE FOR EXTINGUISHING
SURROUNDING FIRE.
Fire Fighting Procedures:WEAR FULL PROTECTIVE CLOTHING & NIOSH APPROVED
SCBA W/FULL FACEPIECE OPERATED IN THE PRESSURE DEMAND/OTHER
POSITIVE PRESSURE MODE.
Unusual Fire/Explosion Hazard:NON-FLAMMABLE.

Accidental Release

Spill Release Procedures:ALL CLEANUP OPERATIONS SHOULD BE PERFORMED
ACCORDING TO THE STANDARD OPERATING PROCEDURES.

Handling

Handling and Storage Precautions:STORE AT 59F-86F. HANDLING TIME SHOULD
BE KEPT TO A MINIMUM & APPROPRIATE SHIELDING SHOULD BE USED. USE
HANDLING DEVICES; AS SYRINGE SHIELDS & TONGS.
Other Precautions:AVOID CONTAMINATION FROM SKIN, EYES/CLOTHING.
RADIOACTIVE DRUGS MUST BE HANDLED BY QUALIFIED PERSONNEL. THE VIAL
CONTAINING THE DRUG SHOULD BE KEPT W/IN IT'S CONTAINER/W/IN HEAVIER
SHIELDING. AVOID CO NTACT W/RADIOACTIVE CONTENTS.

Exposure Controls

Protective Gloves:DISPOSABLE PLASTIC/LATEX/RUBBER
Eye Protection:SAFETY GLASSES
Other Protective Equipment:LABCOAT.
Work Hygienic Practices:NO SMOKING, EATING/DRINKING SHOULD BE ALLOWED
IN ANY AREA WHERE RADIOACTIVE MATERIALS ARE HANDLED/STORED.
Supplemental Safety and Health

Chemical Properties

Boiling Pt:B.P. Text:212F
Melt/Freeze Pt:M.P/F.P Text:32F
Solubility in Water:COMPLETE
Appearance and Odor:CLEAR COLORLESS LIQUID IN A 10ML GLASS VIAL.

Stability

Stability Indicator/Materials to Avoid:YES
Hazardous Decomposition Products:RADIOACTIVE FUMES, GALLIUM CITRATE.

Disposal

Waste Disposal Methods:RADIOACTIVE WASTE MUST BE HANDLED IAW/FEDERAL,
STAET & LOCAL REGULATIONS. UN2982.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.